Pfizer Inc (PFE)

$26.05 +0.16 (0.62%)
Market Cap 145.10B
Revenue (ttm) 63.63B
Net Income (ttm) 8.03B
EPS (ttm) N/A
PE Ratio 8.02
Forward PE 8.65
Profit Margin 12.62%
Debt to Equity Ratio 0.66
Volume 36,597,811
Avg Vol 57,946,980
Day's Range N/A - N/A
Shares Out 5.69B
Stochastic %K 97%
Beta 0.47
Analysts Sell
Price Target $27.95

Company Profile

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular and migraine under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and tre...

Industry: Drug Manufacturers - General
Sector: Healthcare
Phone: 212 733 2323
Address:
66 Hudson Boulevard East, New York, United States
MrMostly
MrMostly Jan. 22 at 8:53 PM
$PFE Given the dividend tomorrow, buying today is actually about $25.50. YOC = 6.7%.
0 · Reply
InterGalacticTraders
InterGalacticTraders Jan. 22 at 8:53 PM
If you have been watching the latest 300% squeezes make sure not to miss SNSE Would not be shocked if they send SNSE up next. It's squeezing now! SNSE starting to make its move now! Only 800k shares supply ! 💎 $CLOV $RVSN $INTC $PFE deals to be made
0 · Reply
Micheal_Pothead
Micheal_Pothead Jan. 22 at 8:35 PM
$PFE not a bad day but certainly a comical one
0 · Reply
CuriouslyPanda
CuriouslyPanda Jan. 22 at 8:02 PM
$PFE $PFE $PFE $25.50 You know, I know it, Everyone Knows it
1 · Reply
10D_west
10D_west Jan. 22 at 7:28 PM
$SPY $MRK $PFE Whatever happened to getting rid of pharmaceutical ads on TV?
2 · Reply
MHM7700
MHM7700 Jan. 22 at 7:22 PM
$PFE 1/23 26c $0.13
0 · Reply
Micheal_Pothead
Micheal_Pothead Jan. 22 at 6:57 PM
$PFE pinned
1 · Reply
autisticboy
autisticboy Jan. 22 at 6:56 PM
$PFE fishing breakouts and selling calls is what they're doing, think it'll stay this way until proper catalyst
0 · Reply
morgangj
morgangj Jan. 22 at 6:56 PM
$PFE UNDERVALUED!
0 · Reply
Micheal_Pothead
Micheal_Pothead Jan. 22 at 6:46 PM
$PFE
0 · Reply
Latest News on PFE
Pfizer CEO Albert Bourla: U.S. drug prices are coming down

Jan 20, 2026, 12:34 PM EST - 2 days ago

Pfizer CEO Albert Bourla: U.S. drug prices are coming down

Drug pricing, patent losses and deals: Here's what pharma execs see ahead in the industry

Jan 20, 2026, 12:18 PM EST - 2 days ago

Drug pricing, patent losses and deals: Here's what pharma execs see ahead in the industry

NVO

Novavax enters license agreement with Pfizer for vaccine development

Jan 20, 2026, 7:11 AM EST - 2 days ago

Novavax enters license agreement with Pfizer for vaccine development

NVAX

Japan's Shionogi boosts ViiV stake to 21.7% as Pfizer exits

Jan 20, 2026, 2:19 AM EST - 2 days ago

Japan's Shionogi boosts ViiV stake to 21.7% as Pfizer exits

Invesco Equity And Income Fund Q4 2025 Portfolio Positioning And Performance

Jan 19, 2026, 8:10 PM EST - 2 days ago

Invesco Equity And Income Fund Q4 2025 Portfolio Positioning And Performance

BDX DD MSFT ORCL PH Q SLB

MoneyShow's Best Investment Ideas For 2026: Part 7

Jan 19, 2026, 2:20 PM EST - 3 days ago

MoneyShow's Best Investment Ideas For 2026: Part 7

PLD PLG PM QUIK RCAT

Pfizer: Rebound Has Just Started

Jan 16, 2026, 1:08 PM EST - 6 days ago

Pfizer: Rebound Has Just Started

Pfizer: The Most Intriguing Value Play Of 2026

Jan 15, 2026, 8:58 AM EST - 7 days ago

Pfizer: The Most Intriguing Value Play Of 2026

Pfizer's Patent Cliff, Rising Debt, And The Fight To Stay A Buy

Jan 13, 2026, 6:11 AM EST - 9 days ago

Pfizer's Patent Cliff, Rising Debt, And The Fight To Stay A Buy

Pfizer CEO plans for soaring consumer market for obesity drugs akin to Viagra

Jan 12, 2026, 6:43 PM EST - 9 days ago

Pfizer CEO plans for soaring consumer market for obesity drugs akin to Viagra

Pfizer Inc. (PFE) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Jan 12, 2026, 3:16 PM EST - 10 days ago

Pfizer Inc. (PFE) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Pfizer's BRAFTOVI® Regimen with Additional Chemotherapy Backbone Increased Response Rates for Certain Patients with Metastatic Colorectal Cancer

Jan 10, 2026, 10:00 AM EST - 12 days ago

Pfizer's BRAFTOVI® Regimen with Additional Chemotherapy Backbone Increased Response Rates for Certain Patients with Metastatic Colorectal Cancer

Healthy Returns: What to expect from pharma at the JPM conference

Jan 9, 2026, 12:57 PM EST - 13 days ago

Healthy Returns: What to expect from pharma at the JPM conference

AMGN AZN BMY LLY MRK NVO

Gordian Bio Announces Research Collaboration with Pfizer to Accelerate In Vivo Target Discovery in Obesity

Jan 8, 2026, 8:00 AM EST - 14 days ago

Gordian Bio Announces Research Collaboration with Pfizer to Accelerate In Vivo Target Discovery in Obesity

Trial Date Has Been Set in MDL against Pfizer for Depo-Provera Overseen by Levin Papantonio

Jan 7, 2026, 2:16 PM EST - 15 days ago

Trial Date Has Been Set in MDL against Pfizer for Depo-Provera Overseen by Levin Papantonio

Quant Q&A With Steven Cress

Jan 7, 2026, 7:00 AM EST - 15 days ago

Quant Q&A With Steven Cress

CLS CRDO ET FIX MRK

America's new vaccine doctrine for children replaces data with dogma

Jan 6, 2026, 11:55 AM EST - 16 days ago

America's new vaccine doctrine for children replaces data with dogma

MRNA

Cartography Biosciences and Pfizer to Collaborate on the Discovery of Tumor-Selective Antigens

Jan 6, 2026, 7:30 AM EST - 16 days ago

Cartography Biosciences and Pfizer to Collaborate on the Discovery of Tumor-Selective Antigens

Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference

Jan 5, 2026, 10:00 AM EST - 17 days ago

Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference

Pfizer 2026: The Reset Year

Jan 2, 2026, 2:52 PM EST - 20 days ago

Pfizer 2026: The Reset Year

3 ultra-high-yield stocks to consider for $300 of dividend income in 2026

Dec 31, 2025, 8:37 AM EST - 22 days ago

3 ultra-high-yield stocks to consider for $300 of dividend income in 2026

AGNC PFLT

Exclusive: Drugmakers raise US prices on 350 medicines despite pressure from Trump

Dec 31, 2025, 6:08 AM EST - 22 days ago

Exclusive: Drugmakers raise US prices on 350 medicines despite pressure from Trump

GSK LLY NVS SNY

Chevron, Kimberly-Clark Among 16 Companies To Kick Off 2026 With Annual Dividend Increases In January

Dec 26, 2025, 10:35 PM EST - 26 days ago

Chevron, Kimberly-Clark Among 16 Companies To Kick Off 2026 With Annual Dividend Increases In January

CVX KMB ABM ABT AMGN AVGO BCPC

Pfizer says patient dies after receiving hemophilia drug in trial

Dec 23, 2025, 11:24 AM EST - 4 weeks ago

Pfizer says patient dies after receiving hemophilia drug in trial

Pfizer Isn't Dead Money, Pipeline Execution Can Spark A Rebound

Dec 19, 2025, 11:45 AM EST - 4 weeks ago

Pfizer Isn't Dead Money, Pipeline Execution Can Spark A Rebound

Trump to announce new drug-pricing deals later today

Dec 19, 2025, 10:45 AM EST - 4 weeks ago

Trump to announce new drug-pricing deals later today

ABBV AMGN AZN BMY GILD LLY MRK

Pfizer Invites Public to View and Listen to Webcast of February 3 Conference Call with Analysts

Dec 18, 2025, 10:00 AM EST - 5 weeks ago

Pfizer Invites Public to View and Listen to Webcast of February 3 Conference Call with Analysts

Pfizer Plays Catchup In Obesity Market, Licenses Weight-loss Drug From Fosun

Dec 18, 2025, 6:58 AM EST - 5 weeks ago

Pfizer Plays Catchup In Obesity Market, Licenses Weight-loss Drug From Fosun

AbbVie, several other pharma companies near MFN deal with Trump, sources say

Dec 17, 2025, 4:11 PM EST - 5 weeks ago

AbbVie, several other pharma companies near MFN deal with Trump, sources say

ABBV AMGN AZN BMY LLY NVS

Pfizer Stock Can Sink More. Here Is How

Dec 17, 2025, 2:36 PM EST - 5 weeks ago

Pfizer Stock Can Sink More. Here Is How

Pfizer, Merck Are Boring Again — And That's Exactly Why 2026 Investors Are Circling Back

Dec 17, 2025, 10:14 AM EST - 5 weeks ago

Pfizer, Merck Are Boring Again — And That's Exactly Why 2026 Investors Are Circling Back

MRK

PADCEV™ Plus Keytruda® Significantly Improves Survival for Patients with Muscle-Invasive Bladder Cancer Regardless of Cisplatin Eligibility

Dec 17, 2025, 6:45 AM EST - 5 weeks ago

PADCEV™ Plus Keytruda® Significantly Improves Survival for Patients with Muscle-Invasive Bladder Cancer Regardless of Cisplatin Eligibility

Pfizer Inc. (PFE) Q4 2026 Guidance Call Transcript

Dec 16, 2025, 2:39 PM EST - 5 weeks ago

Pfizer Inc. (PFE) Q4 2026 Guidance Call Transcript

Pfizer falls on disappointing guidance

Dec 16, 2025, 12:33 PM EST - 5 weeks ago

Pfizer falls on disappointing guidance

Pfizer's modest 2026 outlook shows its big investments will take time to pay off

Dec 16, 2025, 10:12 AM EST - 5 weeks ago

Pfizer's modest 2026 outlook shows its big investments will take time to pay off

Here's why Pfizer is revising its revenue forecasts

Dec 16, 2025, 7:47 AM EST - 5 weeks ago

Here's why Pfizer is revising its revenue forecasts

Pfizer Stock Edges Higher on 2026 Guidance. Expect a Rough Year for Covid Vaccine Sales.

Dec 16, 2025, 7:25 AM EST - 5 weeks ago

Pfizer Stock Edges Higher on 2026 Guidance. Expect a Rough Year for Covid Vaccine Sales.

Pfizer Expects Decline in Covid-19 Drug Demand to Hurt 2026 Earnings

Dec 16, 2025, 7:16 AM EST - 5 weeks ago

Pfizer Expects Decline in Covid-19 Drug Demand to Hurt 2026 Earnings

Pfizer forecasts 2026 profit below expectations on lower COVID product sales

Dec 16, 2025, 6:54 AM EST - 5 weeks ago

Pfizer forecasts 2026 profit below expectations on lower COVID product sales

Pfizer Reaffirms Full-Year 2025 EPS Guidance and Provides Full-Year 2026 Guidance

Dec 16, 2025, 6:45 AM EST - 5 weeks ago

Pfizer Reaffirms Full-Year 2025 EPS Guidance and Provides Full-Year 2026 Guidance

Adaptive Biotechnologies signs non-exclusive deals with Pfizer worth up to $890 million

Dec 15, 2025, 8:24 AM EST - 5 weeks ago

Adaptive Biotechnologies signs non-exclusive deals with Pfizer worth up to $890 million

ADPT

Adaptive Biotechnologies Announces Two Immune Receptor Licensing Agreements with Pfizer

Dec 15, 2025, 8:00 AM EST - 5 weeks ago

Adaptive Biotechnologies Announces Two Immune Receptor Licensing Agreements with Pfizer

ADPT

Pfizer Declares First-Quarter 2026 Dividend

Dec 12, 2025, 12:00 PM EST - 5 weeks ago

Pfizer Declares First-Quarter 2026 Dividend

Dividend Harvesting Portfolio Week 249: $24,900 Allocated, $2,646.53 In Projected Dividends

Dec 12, 2025, 8:45 AM EST - 5 weeks ago

Dividend Harvesting Portfolio Week 249: $24,900 Allocated, $2,646.53 In Projected Dividends

AMLP MO MSTY OHI

Health Rounds: Pfizer drug delays progression of advanced breast cancer in trial

Dec 12, 2025, 7:24 AM EST - 5 weeks ago

Health Rounds: Pfizer drug delays progression of advanced breast cancer in trial

Pfizer to cut hundreds of jobs in Switzerland to reduce costs, Bloomberg News reports

Dec 10, 2025, 11:38 AM EST - 6 weeks ago

Pfizer to cut hundreds of jobs in Switzerland to reduce costs, Bloomberg News reports

TUKYSA Added to First-Line Maintenance Therapy Extends Median Progression-Free Survival by Over 8 Months in Patients with HER2+ Metastatic Breast Cancer

Dec 10, 2025, 8:15 AM EST - 6 weeks ago

TUKYSA Added to First-Line Maintenance Therapy Extends Median Progression-Free Survival by Over 8 Months in Patients with HER2+ Metastatic Breast Cancer

Will Pfizer's YaoPharma deal deliver a powerful new oral obesity pill?

Dec 9, 2025, 3:30 PM EST - 6 weeks ago

Will Pfizer's YaoPharma deal deliver a powerful new oral obesity pill?

Pfizer adds to obesity bet with up to $2.1 billion deal to develop Chinese company's pill

Dec 9, 2025, 11:14 AM EST - 6 weeks ago

Pfizer adds to obesity bet with up to $2.1 billion deal to develop Chinese company's pill

Undisclosed Deaths in the Pfizer mRNA COVID-19 Vaccine Trial Discussed in the Journal of American Physicians and Surgeons

Dec 9, 2025, 10:59 AM EST - 6 weeks ago

Undisclosed Deaths in the Pfizer mRNA COVID-19 Vaccine Trial Discussed in the Journal of American Physicians and Surgeons

MrMostly
MrMostly Jan. 22 at 8:53 PM
$PFE Given the dividend tomorrow, buying today is actually about $25.50. YOC = 6.7%.
0 · Reply
InterGalacticTraders
InterGalacticTraders Jan. 22 at 8:53 PM
If you have been watching the latest 300% squeezes make sure not to miss SNSE Would not be shocked if they send SNSE up next. It's squeezing now! SNSE starting to make its move now! Only 800k shares supply ! 💎 $CLOV $RVSN $INTC $PFE deals to be made
0 · Reply
Micheal_Pothead
Micheal_Pothead Jan. 22 at 8:35 PM
$PFE not a bad day but certainly a comical one
0 · Reply
CuriouslyPanda
CuriouslyPanda Jan. 22 at 8:02 PM
$PFE $PFE $PFE $25.50 You know, I know it, Everyone Knows it
1 · Reply
10D_west
10D_west Jan. 22 at 7:28 PM
$SPY $MRK $PFE Whatever happened to getting rid of pharmaceutical ads on TV?
2 · Reply
MHM7700
MHM7700 Jan. 22 at 7:22 PM
$PFE 1/23 26c $0.13
0 · Reply
Micheal_Pothead
Micheal_Pothead Jan. 22 at 6:57 PM
$PFE pinned
1 · Reply
autisticboy
autisticboy Jan. 22 at 6:56 PM
$PFE fishing breakouts and selling calls is what they're doing, think it'll stay this way until proper catalyst
0 · Reply
morgangj
morgangj Jan. 22 at 6:56 PM
$PFE UNDERVALUED!
0 · Reply
Micheal_Pothead
Micheal_Pothead Jan. 22 at 6:46 PM
$PFE
0 · Reply
STOCKPICKERTRADER
STOCKPICKERTRADER Jan. 22 at 6:30 PM
$PYPL nice upside on the news of this company acquiring another slice of business! Been getting beaten up hard and showing some love last couple days for sure - maybe $PFE should get some pointers on the acquisition business to receive upside instead of gut punch....
0 · Reply
_Crim_Jamer_
_Crim_Jamer_ Jan. 22 at 5:22 PM
$PFE the rotation has begun!
1 · Reply
Micheal_Pothead
Micheal_Pothead Jan. 22 at 5:03 PM
$PFE I didn’t wanna hold the gains anyways
0 · Reply
SPYwatcha
SPYwatcha Jan. 22 at 4:38 PM
$PFE $DHR Bears are covering their shorts, further strengthening the upward trend.
0 · Reply
SaneProton
SaneProton Jan. 22 at 4:34 PM
$MRNA $NVO $PFE Hey this degenerate loser is back lol. This guy is one of those filthy cockroaches that pops in every now again. He’ll always be poor and dumb. No one likes him.
0 · Reply
sister
sister Jan. 22 at 4:31 PM
$MRNA can always buy Cheaper . . . just Sayin. $PFE $NVO too
0 · Reply
dust6431
dust6431 Jan. 22 at 4:29 PM
$PFE True to form, sell it off to even, then minus out dividend, add in markets pull back tomorrow looking at
0 · Reply
knuckleheadinvestco
knuckleheadinvestco Jan. 22 at 4:27 PM
$PFE if you know you know
0 · Reply
Micheal_Pothead
Micheal_Pothead Jan. 22 at 4:17 PM
$PFE typical
0 · Reply
BullMaven
BullMaven Jan. 22 at 4:13 PM
$PFE no brainer . heading to 30+. enjoy div and steady growth
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Jan. 22 at 4:09 PM
Enter: $PFE Calls Strike Price: $26 Expiry Date: FEB 13 2026 Buy in Price: $0.44 - $0.46 Sell Price: $0.84 Profit : +91% (Turn every $1 into $1.91) Want Profitable Real-Time Options Alerts? 👉 https://moneygroup.us/
0 · Reply
barnml2006
barnml2006 Jan. 22 at 4:01 PM
$PFE after 7 painful weeks, finally out of this options trade. $400 profit is total s*** but at least I didn't lose. Good luck to you longs but this one isn't for me. Hope you see $27 a share today, but my skin is no longer in the pfe game.
1 · Reply